Assignee
NYCE JONATHAN WESLEY
US·0 granted patents·4 pending applications·0 citations·filing 2015–2018
Top patents by PatentIndex Score
4 records- 0150US2020129525A1Method to improve quality of life in non-primate animals by administration of Dehydroepiandrosterone Sulfate (DHEAS) sufficient to achieve primate-specific levels of circulating DHEAS that are not natural to the target speciesNYCE JONATHAN WESLEY·Filed 2018·Application pending·0 cites
- 0241US2017007619A1High Dose Dehydroepiandrosterone as Anticancer Treatment With Multi-faceted Reconstitution of Otherwise Depleted MetabolitesNYCE JONATHAN WESLEY·Filed 2015·Application pending·0 cites
- 0341US2017007620A1Method of replenishing steroid hormones in neutered mammals comprising administration of dehydroepiandrosterone (DHEA) and specific metabolites in order to increase steroid hormone levels from those of neutered mammals associated with high cancer risk, to steroid hormone levels of gonadally-intact mammals associated with reduced cancer risk, without inducing the side effects that would occur without metabolite supplementation.NYCE JONATHAN WESLEY·Filed 2015·Application pending·0 cites
- 0439US2017009238A1System of interdependent anticancer antisense oligonucleotides targeting mRNAs the targets of which are NADPH-dependent, combined with one or more inhibitors of the Pentose Phosphate Pathway to deplete NADPHNYCE JONATHAN WESLEY·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NYCE JONATHAN WESLEY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →